Logo
  • Portfolio
  • People
  • Investors
  • News
  • Contact Us
  • Portfolio
  • People
  • Investors
  • News
  • Contact Us

Year: 2022

Press Releases | 15/12/2022

Full Year Results

Press Releases | 28/11/2022

C4XD signs exclusive global licence worth up to $402 million with AstraZeneca for the development and commercialisation of NRF2 Activator programme

Press Releases |

C4XD signs exclusive global licence worth up to $402 million with AstraZeneca for the development and commercialisation of NRF2 Activator programme

Press Releases | 20/10/2022

C4XD and HitGen to collaborate in inflammation hit identification project

Press Releases | 02/08/2022

Revenue generating progress for partnered programmes with continued momentum across drug discovery portfolio

News | 11/07/2022

Bhavna Hunjan wins a Rising Star award for Movers and Shakers in BioBusiness 2017

Press Releases | 06/07/2022

C4X Discovery receives first milestone payment from Sanofi

Scientific Papers | 23/06/2022

SDPD-SX: combining a single crystal X-ray diffraction setup with advanced powder data structure determination for use in early stage drug discovery

News | 19/05/2022

Clive Dix appointed to the Board of Precision Health Technologies Accelerator

News | 28/04/2022

C4X Discovery Holdings PLC on expanding its portfolio

Posts navigation

Older posts

Categories

  • News
  • Press Releases
  • Scientific Papers

Archives

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020

Contact us

contact@c4xdiscovery.com

Copyright ©2026 C4XD Holdings Limited

privacy policy
  • Portfolio
  • People
  • Investors
  • News
  • Contact Us

C4X Discovery Holdings Ltd
1 Park Row
Leeds
LS1 5AB
United Kingdom

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}